Seizures consistently cause an initial drop in hippocampal opioid peptides (from release) followed by overproduction — dynorphin changes are larger and may be anticonvulsant.
Deplete-then-overproduceConsistent pattern across electroshock, kainic acid, and kindling seizure models
What the researchers found
After seizures (from electroshock, kainic acid, or kindling), both dynorphin and enkephalin initially decrease in the hippocampus, indicating release. But their recovery patterns differ dramatically.
Enkephalin shows a rapid, sustained rebound above normal levels after all three seizure types. Dynorphin shows a large, sustained decrease after electroshock and kindling, with slow recovery.
Mu-opioid receptor antagonists shortened the kindling process (where repeated mild stimulation eventually produces seizures). This strongly suggests brain opioid peptides are involved in how seizure susceptibility develops.
Enkephalin in the hippocampus appears to mediate wet-dog shakes (a specific seizure behavior seen in rodents), connecting it to the opioid withdrawal syndrome.
Why it matters
Understanding how seizures affect the brain's opioid system matters for epilepsy treatment. If opioid peptides modulate seizure threshold and seizure-related behaviors, targeting opioid receptors could be a new approach to epilepsy management.
How the study worked
Review of the authors' own experimental work using electroconvulsive shock, kainic acid injection, and amygdaloid kindling in rats. Opioid peptide levels measured by immunoassay. Functional role tested with opioid antagonists and antisera.
What this study cannot tell us
Review of primarily the authors' own work. Results are from rats and may not apply to human epilepsy. The hippocampus was the main focus; other brain regions were less studied.
How to read the evidence
Preliminary — review of animal studies proposing a mechanistic framework.
When this study was published
Published in 1988 — influential review shaping the opioid-epilepsy research field.
The bigger picture
The brain has built-in anti-seizure mechanisms using endogenous opioid peptides. Harnessing this natural protection could lead to new epilepsy treatments.
Questions still open
- Could dynorphin supplementation prevent epilepsy progression?
- Does the rebound mechanism fail in drug-resistant epilepsy?
Common questions
Are opioid peptides anticonvulsant?
Could this lead to new epilepsy drugs?
Read the original research
Seizure-induced alterations in the metabolism of hippocampal opioid peptides suggest opioid modulation of seizure-related behaviors.
NIDA research monograph, 82, 48-66
Citation
Hong, J S; McGinty, J F; Grimes, L; Kanamatsu, T; Obie, J; Mitchell, C L. (1988). Seizure-induced alterations in the metabolism of hippocampal opioid peptides suggest opioid modulation of seizure-related behaviors.. NIDA research monograph, 82, 48-66.